Catrin Hasselgren

Catrin Hasselgren is currently the Executive Director of Predictive Toxicology at Genentech, having previously served as Senior Director in the same field. With a distinguished career that includes roles as a Senior Principal Scientist at Leadscope, Inc., and various positions at AstraZeneca, Catrin has built extensive expertise in computational toxicology. Catrin also founded PureInfo Discovery Inc. in 2015, demonstrating an entrepreneurial spirit alongside their academic tenure as an Assistant Professor at the University of New Mexico. Catrin earned a PhD in Chemistry from Chalmers University of Technology and holds multiple degrees in Chemistry and Biochemistry from esteemed universities.